Aspiriant LLC’s Vanguard FTSE Europe ETF VGK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$332K Hold
4,023
0.01% 265
2025
Q4
$336K Buy
4,023
+730
+22% +$59.3K 0.01% 262
2025
Q3
$263K Hold
3,293
0.01% 270
2025
Q2
$255K Sell
3,293
-18
-0.5% -$1.33K 0.01% 277
2025
Q1
$232K Buy
3,311
+92
+3% +$6.34K 0.01% 269
2024
Q4
$204K Buy
3,219
+198
+7% +$13.2K 0.01% 281
2024
Q3
$215K Hold
3,021
0.01% 275
2024
Q2
$202K Hold
3,021
0.01% 275
2024
Q1
$203K Buy
+3,021
New +$196K 0.01% 309
2022
Q3
Sell
-4,670
Closed -$247K 279
2022
Q2
$247K Buy
+4,670
New +$271K 0.01% 235
2022
Q1
Sell
-3,021
Closed -$206K 301
2021
Q4
$206K Sell
3,021
-100
-3% -$6.77K 0.01% 272
2021
Q3
$205K Hold
3,121
0.01% 225
2021
Q2
$210K Buy
+3,121
New +$211K 0.01% 226
2019
Q3
Sell
-4,000
Closed -$220K 231
2019
Q2
$220K Hold
4,000
0.02% 209
2019
Q1
$214K Buy
+4,000
New +$209K 0.02% 213

Other funds holding VGK

Aspiriant LLC's VGK Position: Q1 2026 in Review

Aspiriant LLC held its Vanguard FTSE Europe ETF (VGK) position steady in Q1 2026 at 4,023 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #265.

Aspiriant LLC first reported a position in VGK in Q1 2019 and has held it in 15 quarters since. The position peaked at $336K in Q4 2025. 885 funds tracked by Wall St. Rank hold VGK as of Q1 2026.

  • Aspiriant LLC held 4,023 shares of Vanguard FTSE Europe ETF worth $332K as of Q1 2026.
  • Aspiriant LLC left its Vanguard FTSE Europe ETF share count unchanged in Q1 2026.
  • Vanguard FTSE Europe ETF made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #265 holding.
  • Aspiriant LLC first reported a position in Vanguard FTSE Europe ETF in Q1 2019 and has held it in 15 quarters since.
  • Aspiriant LLC's Vanguard FTSE Europe ETF position peaked at $336K in Q4 2025.
  • 885 funds tracked by Wall St. Rank held Vanguard FTSE Europe ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.